Laekna, Inc. Advances LAE123 for Severe Diseases
Laekna, Inc. (HK:2105) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At ...
Daily6d
Eli Lilly Collaborates with Laekna to Develop Obesity Drug Targeting Muscle Preservation and Weight Loss
Bengaluru: Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help ...
MM&M8d
Rx Rundown: Novartis, Sage Therapeutics, Eli Lilly and more
Vyriad announced a collaboration with Novartis to develop in vivo CAR T therapies. Eli Lilly teamed up with Chinese biotech ...
The Pharma Letter9d
Lilly and Laekna team up on novel obesity drugs
Eli Lilly has partnered with Laekna to advance LAE102, an antibody targeting the ActRIIA receptor, for obesity and muscle ...
BioSpace9d
Lilly Partners With Chinese Biotech to Advance Muscle-Sparing Obesity Treatment
Lilly will provide the funding and expertise to advance Laekna’s LAE102, a first-in-class monoclonal antibody targeting the ...
devdiscourse9d
Global Health Updates: Innovations and Challenges in Fighting Diseases
Recent developments in health news highlight the CDC's anticipation of increased COVID-19 and RSV cases during the holidays, ...
Laekna, Inc. Announces Share Placement to Raise HK$230 Million
Laekna, Inc. (HK:2105) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...
阿思達克財經網9d
LAEKNA-B Last Slumps 7%+ after Announcing Shr Placing on 48% Rally Ytd
LAEKNA-B (02105.HK) announced a share placing immediately after a 48% share surge yesterday (20th). Today (21st), it opened ...
China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients ...
Eli Lilly in pact with Chinese biotech for novel weight loss therapy
Eli Lilly (LLY) partners with Laekna Therapeutics to develop an obesity therapy that avoids muscle loss. Read more here.
Business Wire10d
Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obe…
Laekna, Inc. (2105.HK) (“Laekna”), a global biotech company focused on novel drug development for metabolic and cancer ...
Le Lézard10d
Attackers Targeting VPNs Account for 28.7 Percent of Ransomware Incidents in Q3 According to Corvus Insurance Cyber Threat Report
Corvus Insurance, a wholly owned subsidiary of The Travelers Companies, Inc., today released its Q3 2024 Cyber Threat Report, The Ransomware Ecosystem is Increasingly Distributed, which showed that ...